whatshot

SCNI   $4.0  7.82% Market Open

Scinai Immunotherapeutics Ltd
show_chart Advanced Chart of SCNI

Current temperature: 4.34
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 1
Target Price Mean 700
Mean unverified/preliminary 700 / 700
Target Price Low / High 700 / 700
Median / STD DEV 700 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy Buy ActivelyBuy
rsi Sell Sell None
macd None None None
stoch None None None
ma20 ActivelyBuy Buy None
ma50 None None None
ma100 ActivelyBuy Buy ActivelyBuy
Candlestick PatternOct. 9, 2024 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US09073Q3039
ceo Mr. Amir Reichman M.B.A., M.Sc.
Website https://www.scinai.com
Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.